Pugatch Consilium provides research, analysis, and strategic advisory support across innovation, intellectual property, life sciences, market access, and public policy.
Our work helps clients understand complex policy and regulatory environments, generate evidence-based insight, and support more informed strategic decision-making.
Rigorous quantitative analysis translating complex policy data into defensible, decision-ready evidence. Our work spans multi-indicator scoring systems, econometric modelling, regression analysis, and interactive digital dashboards.
Structured intelligence on national health, pharmaceutical, and innovation systems — particularly in emerging and high-growth markets. Paired with systematic horizon scanning to surface regulatory shifts, policy risks, and strategic opportunities before they reach the mainstream agenda.
A suite of proprietary AI agents trained on Pugatch Consilium's research corpus and policy expertise, available exclusively to members. Clients use these tools independently to draft position papers, map stakeholder landscapes, chart legislative pathways, and monitor regulatory developments — at a pace no traditional method can match.
We help organisations build the internal policy, communications, and market access capability they need to advocate effectively — from analysing existing challenges and restructuring teams, to onboarding new professionals and developing them along the full advocacy journey.
We analyse existing and anticipated challenges facing your policy, communications, and market access teams — assessing capability gaps, workload distribution, and team composition. Where needed, we redesign job descriptions and recommend structural changes that better align human resources to strategic priorities.
We train and develop policy and market access professionals along the full advocacy journey — from objective setting and landscape analysis to stakeholder engagement, messaging, and execution. Programmes are tailored to the seniority level and strategic context of each team, and can be designed for new hires or experienced practitioners.
All programmes are available on-site or online, and can be structured as a single focused session or a phased multi-module engagement. We work with global pharmaceutical companies, industry associations, patient organisations, and government stakeholders — adapting format, depth, and language to each audience.
Our training follows the same structured methodology embedded in our AI tools — covering every stage from issue identification and landscape analysis through to stakeholder engagement, position paper development, legislative pathway mapping, and execution planning.
Contact us to discuss your area of interest and how we may be able to help.
Contact Us